Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
20:59:41 EDT Thu 02 May 2024
Enter Symbol
or Name
USA
CA



News for U:VRPX from 2023-05-03 to 2024-05-02 - 27 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-30 07:30U:VRPXNews ReleaseVirpax Announces Results of Maximum Tolerated Dose Study for Probudur(TM)
2024-03-26 07:30U:VRPXNews ReleaseVirpax Pharmaceuticals Reports 2023 Year-End Results
2024-02-27 07:31U:VRPXNews ReleaseVirpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price
2024-02-27 07:30U:VRPXNews ReleaseVirpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.
2024-02-07 07:30U:VRPXNews ReleaseVirpax Pharmaceuticals Announces Preliminary Results of ProbudurTM Pilot Study with the U.S. Army Institute of Surgical Research
2023-12-29 07:30U:VRPXNews ReleaseVirpax Pharmaceuticals Announces Results of Special Shareholders Meeting
2023-11-17 07:10U:VRPXNews ReleaseVirpax Pharmaceuticals Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing
2023-11-17 07:00U:VRPXNews Release ‚  Virpax Pharmaceuticals Announces Leadership Transition
2023-11-15 16:15U:VRPXNews ReleaseVirpax Pharmaceuticals Reports 2023 Third Quarter Results and Recent Developments
2023-10-31 08:58U:VRPXNews ReleaseVirpax Pharmaceuticals Announces that Envelta ¢ „ ¢ Remains on Track for Trial in Humans Following FDA Review
2023-10-12 08:02U:VRPXNews ReleaseVirpax Pharmaceuticals Announces Extension of CRADA with the U.S. Army Institute of Surgical Research
2023-10-02 08:58U:VRPXNews ReleaseGerald W. Bruce Appointed President and CEO of Novvae ¢ „ ¢ Pharmaceuticals
2023-09-27 08:58U:VRPXNews ReleaseVirpax Pharmaceuticals Announces Results of Probudur ¢ „ ¢ Dose Escalation Studies
2023-09-26 08:58U:VRPXNews ReleaseVirpax Pharmaceuticals to Present at the LD Micro Main Event XVI
2023-09-21 10:00U:VRPXNews ReleaseAltasciences Chosen by Virpax to Support the Development of a New Drug to Prevent Spread of Flu-like Viruses
2023-09-18 07:58U:VRPXNews ReleaseVirpax Pharmaceuticals Announces the Formation of Novvae ¢ „ ¢ Pharmaceuticals
2023-09-05 09:00U:VRPXNews ReleaseVirpax Pharmaceuticals Updates on Litigation
2023-08-28 08:58U:VRPXNews ReleaseVirpax ‚ ® Pharmaceuticals to Present at H.C. Wainwright 25th Annual Global Investment Conference
2023-08-14 09:00U:VRPXNews ReleaseVirpax Pharmaceuticals Reports 2023 Second Quarter Results and Recent Developments
2023-07-24 07:00U:VRPXNews ReleaseVirpax Pharmaceuticals, Inc. to Ring NASDAQ Closing Bell on July 24, 2023
2023-07-13 08:58U:VRPXNews ReleaseVirpax Pharmaceuticals Files Provisional Patent Application for Intranasal Delivery
2023-06-21 08:00U:VRPXNews ReleaseVirpax Pharmaceuticals Enters into CRADA with the National Advisory Neurological Disorders and Stroke Council
2023-06-20 16:10U:VRPXNews ReleaseVirpax Pharmaceuticals Announces CFO Transition
2023-06-13 08:58U:VRPXNews ReleaseVirpax Pharmaceuticals to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on Tuesday, June 20th to Thursday, June 22nd at 9:00 A.M. ET
2023-05-12 16:08U:VRPXNews ReleaseVirpax Pharmaceuticals Reports 2023 First Quarter Results and Recent Developments
2023-05-10 07:15U:VRPXNews ReleaseVirpax Pharmaceuticals To Present at Upcoming CB Tech Watch Seminar
2023-05-04 08:58U:VRPXNews ReleaseVirpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference May 10-11, 2023